Agalsidase Benefits Renal Histology in Young Patients with Fabry Disease

The effect of early-onset enzyme replacement therapy on renal morphologic features in Fabry disease is largely unknown. Here, we evaluated the effect of 5 years of treatment with agalsidase alfa or agalsidase beta in 12 consecutive patients age 7–33 years (median age, 16.5 years). We performed renal...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Tøndel, Camilla, Bostad, Leif, Larsen, Kristin Kampevold, Hirth, Asle, Vikse, Bjørn Egil, Houge, Gunnar, Svarstad, Einar
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Nephrology 2012
Konular:
Clinical Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3537211/
https://ncbi.nlm.nih.gov/pubmed/23274955
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2012030316
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller